StockData

OSR Health, Inc. (OSRHW) stock

OSRHWOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as OSRH
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $325.06KP/E –Yield –

Earnings

OSR Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of OSR Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

OSR Health has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When OSR Health puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases OSR Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. PRESS RELEASE OF OSR HEALTH, INC., DATED OCTOBER 28, 2026
    Update
  2. PRESS RELEASE ISSUED BY OSR HEALTH, INC., DATED AUGUST 19, 2026, TITLED "OSR HEALTH RECEIVES NASDAQ STAFF DELISTING DETERMINATION; INTENDS TO REQUEST HEARINGS PANEL APPEAL."
    Update
  3. PRESS RELEASE, DATED AUGUST 7, 2026, TITLED "OSR HEALTH ISSUES CLARIFICATION REGARDING PRIOR NASDAQ COMMUNICATION AND SHAREHOLDER LOYALTY CVR PROGRAM"
    Update
  4. PRESS RELEASE, DATED JULY 31, 2026, TITLED "OSR HEALTH SECURES NASDAQ COMMUNICATION: LOYALTY CVR PROGRAM WILL NOT TRIGGER A PRICE ADJUSTMENT"
    Update
  5. PRESS RELEASE, DATED APRIL 29, 2026, TITLED "OSR HOLDINGS EXECUTES DEFINITIVE $815 MILLION GLOBAL LICENSE AGREEMENT FOR VXM01 WITH BCM EUROPE"
    Update
  6. PRESS RELEASE, DATED APRIL 9, 2026, TITLED "OSR HOLDINGS ELIMINATES $2.02 MILLION WARRANT OVERHANG WITH PREMIUM-PRICED CONVERTIBLE NOTE"
    Update
  7. PRESS RELEASE DATED JANUARY 27, 2026, TITLED "OSR HOLDINGS COMPLETES WOORI IO ACQUISITION, SECURES LONG-TERM SHAREHOLDER ALIGNMENT, AND REVIEWS STRATEGIC COMBINATION OF MEDICAL DEVICE SUBSIDIARIES."
    Update
  8. PRESS RELEASE DATED JANUARY 12, 2026 TITLED "VAXIMM, AN OSR COMPANY, RECEIVES BINDING TERM SHEET FROM BCM EUROPE FOR GLOBAL EXCLUSIVE LICENSE OF VXM01 WITH $30M UPFRONT AND UP TO $815M IN MILESTONES"
    Update
  9. PRESS RELEASE DATED NOVEMBER 21, 2025 TITLED "VAXIMM AG, AN OSR COMPANY, ENTERS TERM SHEET WITH BCM EUROPE FOR POTENTIAL VXM01 LICENSE WITH $20M UPFRONT AND UP TO $815M IN MILESTONES."
    Update
  10. PRESS RELEASE DATED OCTOBER 14, 2025 TITLED ''OSR HOLDINGS SIGNS DEFINITIVE AGREEMENT TO ACQUIRE WOORI IO, A PIONEER IN NONINVASIVE GLUCOSE MONITORING WITH POTENTIAL TO TRANSFORM DIABETES CARE.''
    Update
  11. INVESTOR PRESENTATION DATED AUGUST 6, 2025
    Update
  12. PRESS RELEASE, DATED JULY, 24, 2025, ANNOUNCING ENTRY INTO TERM SHEET WITH WOORI IO CO., LTD
    News
  13. PRESS RELEASE, DATED FEBRUARY 14, 2025
    News
  14. PRESS RELEASE, DATED FEBRUARY 13, 2025
    News
  15. 8-K exhibit EX-99.1
    Update